Eisai seeks approval of rufinamide in Japan

Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) submitted a

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE